What are growth-hormone secretagogues?

A growth-hormone secretagogue is a compound that prompts your own pituitary gland to release more of its own growth hormone — rather than injecting growth hormone directly. “Secretagogue” is a five-dollar word for “something that makes a gland secrete.” They come in two families, and both work by knocking on the same gland through two different doors.

That’s the whole concept. The rest is which two families, and why “use your own supply” is the selling point.

The two families you’ll actually run into

Nearly every GH secretagogue sorts into one of two groups: GHRH analogs and ghrelin mimetics (often labeled GHRPs, for growth-hormone-releasing peptides). The split is about which receptor they press. The pituitary carries two separate “release growth hormone” buttons, one for each natural signal — and the two families each copy one of those signals. Push either button and the pituitary lets out a pulse of growth hormone; push both at once and the pulse is bigger than either alone. That last detail is why so many people in the growth-hormone space run one compound from each family together, which we’ll come back to.

GHRH analogs: sermorelin, CJC-1295, tesamorelin

GHRH analogs are lab-made copies of growth-hormone-releasing hormone (GHRH) — the message your hypothalamus, a control center in the brain, sends to tell the pituitary “time for some growth hormone.” Copy that message accurately and the same order gets carried out.

Three you’ll meet most often. Sermorelin is the short, original version — essentially the working fragment of natural GHRH, cleared from the blood within minutes. CJC-1295 is the same idea re-engineered to last: a “DAC” version latches onto albumin, a carrier protein in your blood, so a single shot keeps the signal going for days instead of minutes. Tesamorelin is a stabilized GHRH analog and the standout of the group — it’s the one compound in this whole category with a full FDA approval, for a specific job (shrinking deep visceral belly fat in people with HIV-associated fat redistribution). All three bind the same GHRH receptor; they mostly differ in how long they hang around.

Ghrelin mimetics and GHRPs: ipamorelin, and the oral outlier MK-677

The second family copies a different signal entirely: ghrelin, the “hunger hormone” your stomach releases when it’s empty. Ghrelin moonlights — besides making you hungry, it also flips a GH-release switch on the pituitary. Mimic ghrelin at that switch and you get the growth-hormone pulse without necessarily caring about the appetite side of the job.

Ipamorelin is the clean example: a small, selective agonist — “agonist” meaning it flips the same switch the natural hormone does — built to trigger a GH pulse without dragging up stress hormones like cortisol the way older, blunter GHRPs tended to. The odd one out is MK-677 (ibutamoren): it hits the same ghrelin receptor, but it isn’t a peptide and it isn’t a shot. It’s a small molecule stable enough to survive your stomach acid, so it works as a once-daily pill — the rare member of this category you swallow instead of inject.

Why “make your body release its own” is the whole pitch

The reason to bother with any of this, instead of just injecting growth hormone, is that a secretagogue works through your own pituitary — so the growth hormone comes out the way your body normally does it. Your body doesn’t release GH in a steady drip; it releases it in pulses, the largest during deep sleep. Injected growth hormone ignores that rhythm, holds levels high around the clock, and switches off your own production while it’s there. A secretagogue instead amplifies the natural pulses and leaves the body’s own feedback brake in place — the valve that says “enough” when levels climb. In plain terms: it turns up the dial on a system you already run, rather than bypassing it. Whether that translates into the results people are after is a separate question — but as a starting design, working with the body’s own loop is the more physiological bet.

It’s also why the two families get paired. A GHRH analog and a ghrelin mimetic press two different buttons, and together they produce a larger pulse than either does solo — which is the entire logic behind the popular CJC-1295 and ipamorelin combination.

The honest limits: evidence, approval, and sport

Here’s where the enthusiasm needs a leash. How well these work depends heavily on the specific compound and the goal. “Does it raise growth hormone on a blood test?” is well documented for several of them — that part is real and repeatable. “Does that extra growth hormone become visible muscle, faster healing, or fat loss in an otherwise healthy adult?” is a much thinner story, backed far less often than the marketing implies. The compounds don’t share one evidence grade, so it pays to check how strong the evidence actually is for each one before you trust the pitch.

Two hard facts to carry with you. First, approval: tesamorelin is the lone FDA-approved compound in this group, and only for that HIV-related fat condition — the others (CJC-1295, ipamorelin, MK-677 and the rest) are sold “for research use only,” which is a regulatory status, not a stamp of quality or safety. Second, sport: every compound that pushes on the growth-hormone axis is banned in competitive sport at all times — the world anti-doping code names growth-hormone secretagogues and releasing factors outright. If you’re drug-tested, this entire category is off the table.

Where to go next

For the full picture with real sources, start at the growth-hormone hub, which gathers the whole family in one place. If the vocabulary here is new, what peptides even are lays the groundwork in plain English. And when you’re ready to judge a single compound, tesamorelin — the one with an FDA approval behind it — is the clearest place to see what solid evidence looks like in this corner of the field.